Outcomes from treatment of Granulomatous lobular mastitis

Background: Granulomatous lobular mastitis (GLM) is an uncommon benign breast condition characterized by non-caseating Granulomatous inflammation arising from the lobules of the breast. Current therapeutic options include observation, percutaneous aspiration, antibiotics, steroids, methotrexate, and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yuliya B. Olimpiadi, Kirstyn E. Brownson, Li Ding, Stephen F. Sener
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Idiopathic granulomatous mastitis Granulomatous lobular mastitis Surgery RD1-811
Acceso en línea:	https://doaj.org/article/d80595b7aadd4cf5a8683d12a466480f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d80595b7aadd4cf5a8683d12a466480f
record_format	dspace
spelling	oai:doaj.org-article:d80595b7aadd4cf5a8683d12a466480f2021-12-02T05:03:42ZOutcomes from treatment of Granulomatous lobular mastitis2666-262010.1016/j.sipas.2021.100045https://doaj.org/article/d80595b7aadd4cf5a8683d12a466480f2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666262021000218https://doaj.org/toc/2666-2620Background: Granulomatous lobular mastitis (GLM) is an uncommon benign breast condition characterized by non-caseating Granulomatous inflammation arising from the lobules of the breast. Current therapeutic options include observation, percutaneous aspiration, antibiotics, steroids, methotrexate, and surgical procedures. This study evaluated the effectiveness of therapeutic modalities on the duration of disease and recurrence rate. Study design: A retrospective analysis was performed of clinical, radiographic, and therapeutic data for patients presenting with GLM from January 2008 until October 2018. All patients had a core breast biopsy demonstrating granulomas. Patients with other known sources of granulomas were identified. The use of observation, steroids, methotrexate, abscess aspiration, and surgical procedures was evaluated. Results: There were 285 female patients, predominantly Hispanic (n = 265, 93%) with mean age of 35.6 ± 8.7 years at time of diagnosis. The majority of patients (n = 213, 75%) presented with a mass, mean size 4.2 ± 2.5 cm. Twelve (4%) patients had coexisting autoimmune diseases. Antibiotics were utilized in 217 (76%) patients for courses that averaged 3.4 ± 2.2 weeks. Glucocorticoids were used in 80 (28%) patients, and methotrexate was used in 16 (5%). Incision and drainage or surgical excision was performed for 76 (27%) of patients. The median duration of disease was 16 (IQR: 7–33) weeks and the overall recurrence rate was 22%. Both duration of disease and recurrence rate were highest amongst patients treated with a surgical intervention. Conclusions: The self-limited course of disease and relatively low recurrence rate, in addition to longer disease duration and increased recurrence rate noted in patients treated with incision and drainage and/or surgical excision, appears to justify the infrequent use of surgical procedures in the management of GLM.Yuliya B. OlimpiadiKirstyn E. BrownsonLi DingStephen F. SenerElsevierarticleIdiopathic granulomatous mastitisGranulomatous lobular mastitisSurgeryRD1-811ENSurgery in Practice and Science, Vol 7, Iss , Pp 100045- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Idiopathic granulomatous mastitis Granulomatous lobular mastitis Surgery RD1-811
spellingShingle	Idiopathic granulomatous mastitis Granulomatous lobular mastitis Surgery RD1-811 Yuliya B. Olimpiadi Kirstyn E. Brownson Li Ding Stephen F. Sener Outcomes from treatment of Granulomatous lobular mastitis
description	Background: Granulomatous lobular mastitis (GLM) is an uncommon benign breast condition characterized by non-caseating Granulomatous inflammation arising from the lobules of the breast. Current therapeutic options include observation, percutaneous aspiration, antibiotics, steroids, methotrexate, and surgical procedures. This study evaluated the effectiveness of therapeutic modalities on the duration of disease and recurrence rate. Study design: A retrospective analysis was performed of clinical, radiographic, and therapeutic data for patients presenting with GLM from January 2008 until October 2018. All patients had a core breast biopsy demonstrating granulomas. Patients with other known sources of granulomas were identified. The use of observation, steroids, methotrexate, abscess aspiration, and surgical procedures was evaluated. Results: There were 285 female patients, predominantly Hispanic (n = 265, 93%) with mean age of 35.6 ± 8.7 years at time of diagnosis. The majority of patients (n = 213, 75%) presented with a mass, mean size 4.2 ± 2.5 cm. Twelve (4%) patients had coexisting autoimmune diseases. Antibiotics were utilized in 217 (76%) patients for courses that averaged 3.4 ± 2.2 weeks. Glucocorticoids were used in 80 (28%) patients, and methotrexate was used in 16 (5%). Incision and drainage or surgical excision was performed for 76 (27%) of patients. The median duration of disease was 16 (IQR: 7–33) weeks and the overall recurrence rate was 22%. Both duration of disease and recurrence rate were highest amongst patients treated with a surgical intervention. Conclusions: The self-limited course of disease and relatively low recurrence rate, in addition to longer disease duration and increased recurrence rate noted in patients treated with incision and drainage and/or surgical excision, appears to justify the infrequent use of surgical procedures in the management of GLM.
format	article
author	Yuliya B. Olimpiadi Kirstyn E. Brownson Li Ding Stephen F. Sener
author_facet	Yuliya B. Olimpiadi Kirstyn E. Brownson Li Ding Stephen F. Sener
author_sort	Yuliya B. Olimpiadi
title	Outcomes from treatment of Granulomatous lobular mastitis
title_short	Outcomes from treatment of Granulomatous lobular mastitis
title_full	Outcomes from treatment of Granulomatous lobular mastitis
title_fullStr	Outcomes from treatment of Granulomatous lobular mastitis
title_full_unstemmed	Outcomes from treatment of Granulomatous lobular mastitis
title_sort	outcomes from treatment of granulomatous lobular mastitis
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/d80595b7aadd4cf5a8683d12a466480f
work_keys_str_mv	AT yuliyabolimpiadi outcomesfromtreatmentofgranulomatouslobularmastitis AT kirstynebrownson outcomesfromtreatmentofgranulomatouslobularmastitis AT liding outcomesfromtreatmentofgranulomatouslobularmastitis AT stephenfsener outcomesfromtreatmentofgranulomatouslobularmastitis
_version_	1718400679912931328

Outcomes from treatment of Granulomatous lobular mastitis

Ejemplares similares